This trial will use MRIs to look for effects of a new triple-combination therapy in 6-8 year olds.
2 Primary · 2 Secondary · Reporting Duration: 1 year
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
44 Total Participants · 2 Treatment Groups
Primary Treatment: 129Xe · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 6 - 8 · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How is 129Xe impacting the wellbeing of individuals?
"There is substantial clinical evidence that 129Xe treatment is safe, leading our team to assign a score of 3." - Anonymous Online Contributor
Is enrollment in this experiment still an option for interested participants?
"According to clinicaltrials.gov, this study is presently recruiting participants - the initial posting date was May 1st 2022 and it has since been revised on August 24th of the same year." - Anonymous Online Contributor
Am I eligible to join this experiment?
"This clinical investigation is seeking 44 participants with cystic fibrosis aged 6 to 8. Essential eligibility criteria includes: the ability to comply with visit and protocol schedules, sweat chloride levels of 60 mEq/liter or more, two well-documented CFTR gene mutations, written consent from subjects (and assent if applicable), no change in maintenance therapies within 28 days prior to enrollment, willingness to undergo MRI scans and a physician's intent to administer triple combination therapy." - Anonymous Online Contributor
What is the limit to how many participants are accepted into this experiment?
"Affirmative. Per clinicaltrials.gov, this medical research project is actively recruiting participants since its initial posting on May 1st 2022 and most recently updated August 24th 2022. 44 individuals need to be enrolled from a single location." - Anonymous Online Contributor
Is this research trial open to individuals aged 75 or older?
"According to the study's prerequisites, participants must be between 6 and 8 years old." - Anonymous Online Contributor